184 related articles for article (PubMed ID: 34023110)
1. Dysplastic Nevi: Morphology and Molecular and the Controversies In-between.
Wiedemeyer K; Hartschuh W; Brenn T
Surg Pathol Clin; 2021 Jun; 14(2):341-357. PubMed ID: 34023110
[TBL] [Abstract][Full Text] [Related]
2. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
3. Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
Roush GC; Barnhill RL
Br J Cancer; 1991 Nov; 64(5):943-7. PubMed ID: 1931621
[TBL] [Abstract][Full Text] [Related]
4. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
Xavier-Junior JCC; Ocanha-Xavier JP
Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
[TBL] [Abstract][Full Text] [Related]
5. [Dysplastic melanocytic nevus].
Salava A; Ranki A; Saksela O
Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic nevus part II: Dysplastic nevi: Molecular/genetic profiles and management.
Spaccarelli N; Drozdowski R; Peters MS; Grant-Kels JM
J Am Acad Dermatol; 2023 Jan; 88(1):13-20. PubMed ID: 36252690
[TBL] [Abstract][Full Text] [Related]
7. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives.
Albert LS; Rhodes AR; Sober AJ
J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967
[TBL] [Abstract][Full Text] [Related]
8. Dysplastic nevi.
Farber MJ; Heilman ER; Friedman RJ
Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
[TBL] [Abstract][Full Text] [Related]
9. Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.
Melamed RD; Aydin IT; Rajan GS; Phelps R; Silvers DN; Emmett KJ; Brunner G; Rabadan R; Celebi JT
J Invest Dermatol; 2017 Apr; 137(4):905-909. PubMed ID: 27890785
[TBL] [Abstract][Full Text] [Related]
10. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
11. Is it necessary to perform eye examination for patients with cutaneous atypical nevi?
Karaarslan I; Yagcı A; Acar A; Sahin A; Ozkapu T; Palamar M; Ozdemir F
Dermatol Ther; 2020 Nov; 33(6):e14503. PubMed ID: 33142003
[TBL] [Abstract][Full Text] [Related]
12. Prediction of histologic melanocytic dysplasia from clinical observation.
Roush GC; Dubin N; Barnhill RL
J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
[TBL] [Abstract][Full Text] [Related]
13. The limited specificity of histological examination in the diagnosis of dysplastic nevi.
Rabkin MS
J Cutan Pathol; 2008 Nov; 35 Suppl 2():20-3. PubMed ID: 18976415
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and nuclear morphometry for the classification of dysplastic nevi.
Williams RA; Baak JP; Meijer GA; Charlton IG
Anal Quant Cytol Histol; 1999 Oct; 21(5):437-44. PubMed ID: 10560527
[TBL] [Abstract][Full Text] [Related]
15. The dysplastic nevus: recognition and management.
Barnhill RL; Hurwitz S; Duray PH; Arons MS
Plast Reconstr Surg; 1988 Feb; 81(2):280-9. PubMed ID: 3275948
[TBL] [Abstract][Full Text] [Related]
16. The histopathology of dysplastic nevi. Continued controversy.
Roth ME; Grant-Kels JM; Ackerman AB; Elder DE; Friedman RJ; Heilman ER; Maize JC; Sagebiel RW
Am J Dermatopathol; 1991 Feb; 13(1):38-51. PubMed ID: 2003647
[TBL] [Abstract][Full Text] [Related]
17. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
18. Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.
Gao L; van den Hurk K; Moerkerk PTM; Goeman JJ; Beck S; Gruis NA; van den Oord JJ; Winnepenninckx VJ; van Engeland M; van Doorn R
J Invest Dermatol; 2014 Dec; 134(12):2957-2966. PubMed ID: 24999589
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and D3 expression in melanocytic skin lesions.
Alekseenko A; Wojas-Pelc A; Lis GJ; Furgał-Borzych A; Surówka G; Litwin JA
Arch Dermatol Res; 2010 Sep; 302(7):545-50. PubMed ID: 20496072
[TBL] [Abstract][Full Text] [Related]
20. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.
Elder DE; Goldman LI; Goldman SC; Greene MH; Clark WH
Cancer; 1980 Oct; 46(8):1787-94. PubMed ID: 7427881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
